SEC Form 4 · accession 0001209191-17-025827
Aravive, Inc. · ARAV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay S Stout
Officer — SVP, Technical Operations
Period of report
Apr 3, 2017
Accepted (ET)
Apr 5, 2017 · 7:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513818
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 3, 2017 | A | 45,000 | $0.00 | A | 46,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $21.30 | Apr 3, 2017 | A | 75,000 | A | — | Apr 2, 2027 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1Represents the grant of Restricted Stock Units that vest as follows: 25% of the shares subject to the Restricted Stock Units vest on each of April 3, 2018, April 3, 2019, April 3, 2020 and April 3, 2021.
- F225% of the shares subject to the option become exercisable on April 3, 2018 and 1/48 of the shares subject to the option become exercisable monthly thereafter